Vita Coco (NASDAQ:COCO) Upgraded at Wall Street Zen

Key Points

• Wall Street Zen upgraded Vita Coco from a "sell" to a "buy", joining other firms (Wells Fargo, Jefferies, Goldman) that have raised price targets into the roughly $70–78 range and leaving a consensus target of about $69 with an average "Moderate Buy" rating.
• Vita Coco reported a strong Q1 beat—$0.50 EPS vs. $0.34 est. and $179.8M revenue (≈+37% YoY)—and raised full‑year revenue/EBITDA guidance, which has been the primary catalyst for the recent rally.
• Offsetting factors include significant recent insider selling (477,800 shares), high institutional ownership (~88%), and headline risks from investor litigation and potential geopolitical supply‑chain/cost pressures.

Vita Coco (NASDAQ:COCO - Get Free Report) was upgraded by analysts at Wall Street Zen from a "sell" rating to a "buy" rating in a research note issued to investors on Saturday.

Other equities analysts have also issued reports about the stock. Wells Fargo & Company raised their target price on shares of Vita Coco from $60.00 to $75.00 and gave the stock an "overweight" rating in a research report on Thursday. The Goldman Sachs Group reaffirmed a "buy" rating and set a $71.00 target price on shares of Vita Coco in a research report on Thursday. Jefferies Financial Group lifted their price objective on shares of Vita Coco from $63.00 to $78.00 and gave the company a "buy" rating in a report on Thursday. Piper Sandler reissued an "overweight" rating and set a $70.00 price objective on shares of Vita Coco in a report on Wednesday. Finally, Weiss Ratings reissued a "buy (b-)" rating on shares of Vita Coco in a report on Friday, March 27th. Seven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Vita Coco has an average rating of "Moderate Buy" and a consensus target price of $69.00.

Vita Coco Stock Performance

Shares of NASDAQ:COCO opened at $66.75 on Friday. The firm has a market cap of $3.81 billion, a PE ratio of 48.72, a price-to-earnings-growth ratio of 1.62 and a beta of 0.72. The firm's 50 day simple moving average is $52.70 and its 200-day simple moving average is $51.20. Vita Coco has a one year low of $30.54 and a one year high of $69.58.

Vita Coco (NASDAQ:COCO - Get Free Report) last issued its earnings results on Wednesday, April 29th. The company reported $0.50 EPS for the quarter, topping analysts' consensus estimates of $0.34 by $0.16. The business had revenue of $179.77 million for the quarter, compared to analyst estimates of $148.39 million. Vita Coco had a net margin of 12.59% and a return on equity of 25.43%. The company's quarterly revenue was up 37.4% compared to the same quarter last year. During the same period last year, the company posted $0.31 earnings per share. Equities research analysts predict that Vita Coco will post 1.72 EPS for the current fiscal year.

Insider Activity at Vita Coco

In other Vita Coco news, Director Ira Liran sold 30,000 shares of Vita Coco stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $56.65, for a total value of $1,699,500.00. Following the transaction, the director directly owned 572,579 shares of the company's stock, valued at approximately $32,436,600.35. The trade was a 4.98% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Martin Roper sold 25,000 shares of Vita Coco stock in a transaction on Wednesday, April 8th. The stock was sold at an average price of $50.95, for a total transaction of $1,273,750.00. Following the completion of the transaction, the chief executive officer directly owned 298,484 shares in the company, valued at $15,207,759.80. This represents a 7.73% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 477,800 shares of company stock valued at $27,053,262 over the last quarter. 32.30% of the stock is owned by insiders.

Hedge Funds Weigh In On Vita Coco

Institutional investors and hedge funds have recently bought and sold shares of the company. New York State Common Retirement Fund grew its holdings in Vita Coco by 10.3% in the third quarter. New York State Common Retirement Fund now owns 511,031 shares of the company's stock worth $21,703,000 after purchasing an additional 47,632 shares during the last quarter. Westfield Capital Management Co. LP purchased a new position in Vita Coco in the third quarter worth $45,135,000. Hussman Strategic Advisors Inc. acquired a new stake in shares of Vita Coco during the third quarter worth $2,230,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Vita Coco during the third quarter valued at $62,815,000. Finally, American Century Companies Inc. grew its holdings in shares of Vita Coco by 648.0% during the third quarter. American Century Companies Inc. now owns 647,257 shares of the company's stock valued at $27,489,000 after buying an additional 560,729 shares during the last quarter. 88.49% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Vita Coco

Here are the key news stories impacting Vita Coco this week:

• Positive Sentiment: Strong Q1 beat and raised guidance — COCO reported $0.50 EPS and ~ $180M revenue (≈+37% YoY), beat estimates, and raised full‑year revenue/EBITDA guidance; that print is the main catalyst for the recent rally. Press Release
• Positive Sentiment: Analyst upgrades and higher targets — Wells Fargo raised its price target to $75 and put an Overweight on COCO, and other banks (Goldman, Jefferies, Evercore) have also issued buy/outperform views, reinforcing buy‑side interest. Benzinga
• Positive Sentiment: Momentum/quality recognition — COCO was highlighted on Zacks’ momentum list and picked up coverage noting a 95+ composite rating, supporting the growth narrative among momentum investors. Zacks Momentum MSN: 95+ Rating
• Neutral Sentiment: Insider selling (planned 10b5‑1 trades) — CEO, COO and Chairman disclosed multiple share sales (large blocks in late April). These trades increase float near recent highs but were executed under pre‑arranged 10b5‑1 plans, which lowers governance alarm. Investors should watch follow‑through selling. SEC Form 4
• Neutral Sentiment: High institutional ownership — Institutions own ~88% of shares, which can amplify moves (momentum on the upside, or rapid rotation on any negative news). MarketBeat Profile
• Negative Sentiment: Investor litigation risk — Pomerantz announced an investigation into COCO, which can create headline risk, legal costs, and distracted management focus if it develops. PR Newswire
• Negative Sentiment: New geopolitical risk disclosure — The company flagged heightened geopolitical tensions as a potential pressure on costs, supply chain and margins; worsening conditions could hit gross margins or availability. TipRanks
• Negative Sentiment: Longer‑term skepticism — Some analysts/commentaries caution that COCO’s category is niche and competition could cap long‑term upside, tempering valuation expectations after the run. Seeking Alpha

About Vita Coco

Vita Coco, Inc NASDAQ: COCO is a global beverage company specializing in coconut-based products. Founded in 2004 by Michael Kirban and Ira Liran, the company pioneered the introduction of refrigerated coconut water to U.S. consumers. Headquartered in New York City, Vita Coco sources coconuts from growers in tropical regions such as the Philippines, Indonesia and Brazil, partnering with local farmers to promote sustainable agriculture and community development.

The company's flagship offering, Vita Coco Original Coconut Water, is available in multiple pack sizes and a variety of flavors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.